Eyecelerator @ AAO 2024 | S4: Unexpected Bottlenecks in Glaucoma Innovation
Автор: Eyecelerator
Загружено: 2026-01-20
Просмотров: 15
Описание:
Many factors can slow or block innovation. FDA, reimbursement, and practice dynamics all can impede advancement to the marketplace. Patent wars are beginning to stifle innovation as companies are spending more money on legal fees than R&D. Is incremental innovation becoming more of the norm due to increasing barriers to disruptive innovation?
Moderators: Nathan M. Radcliffe, MD and Oluwatosin U. Smith, MD
Panel:
Gus DeMoraes, MD, PhD, MPH, Chief Medical Officer, ORA
Kate Hunt, Chief Commercial Officer Nova Eye Medical
Rajesh Rajpal, MD, Chief Medical Officer, Vision, Johnson & Johnson
Andrew Stewart, President, Global Pharmaceuticals & International Strategy, Bausch + Lomb
Ramin Valian, AbbVie, VP, Eyecare & Global Pipeline & Commercialization Strategy
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: